Kesäniemi Ya

发表

Relevance of the reduction of triglycerides in the prevention of coronary heart disease.

Kesäniemi Ya, 1998 .

Low-density lipoprotein particle composition: what is the contribution to atherogenicity?

Kesäniemi Ya, Rudel Ll, 2000 .

Intravenous galactose elimination tests with and without ethanol loading in various clinical conditions.

Kesäniemi Ya, Salaspuro Mp, 1973 .

Metabolic epidemiology of plasma cholesterol.

Miettinen Ta, Kesäniemi Ya, 1988 .

Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study

V. Salomaa, J. Tuomilehto, H. Miettinen, 2005, Diabetologia.

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

P Glasziou, M. Laakso, A. Keech, 2005, The Lancet.

Trends in coronary events in Finland during 1983-1997. The FINAMI study.

V. Salomaa, M. Niemelä, J. Tuomilehto, 2003, European heart journal.

Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima‐media thickness

A. Rantala, A. Reunanen, M. Savolainen, 2001, European journal of clinical investigation.

Sex-related differences in autonomic modulation of heart rate in middle-aged subjects.

H V Huikuri, H. Huikuri, A. Rantala, 1996, Circulation.

Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland

J. Stengård, J. Kaprio, J. Tuomilehto, 1992, Diabetologia.

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.

M. Nieminen, M. Taskinen, H. Kauma, 1997, Circulation.

Prevalence of the metabolic syndrome in drug‐treated hypertensive patients and control subjects

A. Rantala, A. Reunanen, M. Savolainen, 1999, Journal of internal medicine.

Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.

Y. Marcel, M. Savolainen, Y. Kesäniemi, 1992, Journal of lipid research.

Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland

J. Viikari, T. Ebeling, M. Savolainen, 1992, Journal of internal medicine.

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes

Russell Scott, James D. Best, Merryn Voysey, 2012, Diabetes Care.

Increased pulse pressure is associated with reduced baroreflex sensitivity

H. Huikuri, A. Jula, J. Airaksinen, 2004, Journal of Human Hypertension.

Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men

A. Reunanen, M. Savolainen, H. Kauma, 2000, European journal of clinical investigation.

The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes

H. Kauma, Y. Kesäniemi, O. Ukkola, 2005, Diabetologia.

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

V. Gebski, A. Keech, P. Glasziou, 2011, Diabetologia.

Lack of association between polymorphisms of catalase, copper–zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus

M. Savolainen, Y. Kesäniemi, O. Ukkola, 2001, Journal of internal medicine.

Five‐year risk of developing clinical diabetes after first myocardial infarction; the FINAMI study

V. Salomaa, M. Niemelä, J. Tuomilehto, 2005, Diabetic medicine : a journal of the British Diabetic Association.

Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy.

H. Huikuri, A. Rantala, M. Ikäheimo, 1996, Hypertension.